TF and COVID-19: We investigated the presence of TF-bearing EVs in the plasma of severe COVID-19 patients and found that not only was there an increased concentration of TF+ EVs in the plasma of the patients (Figure 2A), but also that TF-bearing EVs increased their representativity, with an increased percentage of circulating EVs expressing TF on their surface compared to control (Figure 2B).